Abstract
To define the clinical course of patients with benign esophageal stricture treated with bougienage, we reviewed the records of 76 patients undergoing dilatation. Patients with the diagnosis of scleroderma and those with previous hiatal hernia repair or gastric surgery were excluded. Initial evaluation included contrast study, esophagoscopy, and biopsy. Patients underwent a series of dilatations until a 44-Fr or larger bougie was passed. Patients were then instructed to return for recurrence of dysphagia. In this group, mean duration of follow-up from the first dilatation was 21.1 months. A total of 569 dilatations were performed with one major complication and no mortality. Benign esophageal stricture recurred in 65% of patients. After two or more recurrences, the likelihood of requiring an additional dilatation was 86–94% after each recurrence. The interval between required dilatations was variable; however, after 8 dilatations, it approximated once monthly. The shorter mean follow-up time of patients requiring a single dilatation (9.7 months) compared to those requiring multiple dilatations (28.8 months) suggests that the recurrence rates noted in this study are underestimations. In spite of high recurrence rates and short recurrence intervals, the low morbidity and absent mortality over long-term follow-up suggests that repeated bougienage is, an effective modality for the management of benign esophageal stricture.
Similar content being viewed by others
References
Hildreth CT: Stricture of the esophagus. N Engl J Med Surg 10:235, 1821
Larrain A, Csendes A, Pope CE: Surgical correction of reflux: An effective therapy for esophageal strictures. Gastroenterology 69:578, 1975
Hill CD, Gelfand M, Baurermeister: Simplified management of reflux esophagitis with stricture. Ann Surg 172:638, 1970
Bolstad DS: The management of strictures of the esophagus. Ann Otol Rhinol Laryngol 75:1019, 1966
Payne WS, Olsen AM: The Esophagus, Philadelphia, Lea and Febiger, 1974
Lanza FL, Graham DY: Bougienage is effective therapy for most benign esophageal strictures. J Am Med Assoc 240:844, 1978
Ogilvie AL, Ferguson R, Atkinson M: Outlook with conservative treatment of peptic oesophageal stricture. Gut 21:23, 1980
Behar J, Shehan DG, Biancani P, Spiro HM, Storer EH: Medical and Surgical management of reflux esophagitis. N Engl J Med 293:263, 1975
Behar J, Brand DC, Brown FC, Castell DO, Cohen S, Crossley RJ, Pope CE, Winans CS. Cimetidine in the treatment of symptomatic gastroesophageal reflux. Gastroenterology 74:441, 1978
Hogan WJ, Viegas de Andrade SR, Winship DH: Ethanolinduced acute esophageal motor dysfunction. J Appl Phys 32:755, 1972
Winship DH, Caflisch CR, Zboralski FF, Hogan WJ: Deterioration of esophageal peristalsis in patients with alcoholic neuropathy. Gastroenterology 55:173, 1968
Dennish GW, Castell DO. Inhibitory effect of smoking on the lower esophageal sphincter. N Engl J Med 284:1136, 1971
Stanciu C, Bennett JR: Smoking and gastro-oesophageal reflux. Br Med J 3:793, 1972
Christensen J: Effects of drugs on esophageal motility. Arch Intern Med 136:532, 1976
Brand DL, Eastwood IR, Martin D, Carter WB, Pope CE: Esophageal symptoms, manometry, and histology before and after antireflux surgery. A long term follow-up study. Gastroenterology 76:1393, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Glick, M.E. Clinical course of esophageal stricture managed by bougienage. Digest Dis Sci 27, 884–888 (1982). https://doi.org/10.1007/BF01316571
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01316571